Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1532605

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1532605

Linear Particle Accelerators Market - Product Type, Treatment Type, Application, End user - Global Forecast

PUBLISHED:
PAGES: 193 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Linear Particle Accelerators Market size is poised to record 5.9% CAGR from 2024-2032, on account of expanding usage in radiation-based technologies, including medical imaging, radiation therapy, and industrial processing. The development and modernization of healthcare facilities, including cancer treatment centers and research institutions, are driving the demand for advanced electron linacs linear accelerators. New installations and upgrades to the existing facilities are increasing the need for several state-of-the-art technologies. Significant investments in scientific and healthcare infrastructure will also play an important role in the market growth.

The linear particle accelerators industry is segmented into product type, technology, treatment type, application, end-user, and region.

In terms of technology, the market value from the electron segment will witness lucrative CAGR through 2032, driven by versatile applications in medical, industrial, and research fields to meet the increasing need for precision and efficiency. Modern electron linacs offer high precision in radiation delivery, which is crucial for applications requiring accurate dose distribution. Technological advancements to offer enhanced performance, including better beam quality, higher energy levels, and more efficient operation will push the segment growth.

With respect to application, the linear particle accelerators industry from the lung cancer segment is expected to expand from 2024 to 2032. The growth can be attributed to the rising need to offer precise, high-dose radiation delivery with minimal impacts on surrounding healthy tissues. With advanced imaging and treatment planning capabilities to enhance effectiveness and safety, these accelerators have emerged as valuable tools in the management of lung cancer.

Regionally, the Asia Pacific linear particle accelerators market size is expected to observe decent growth from 2024 to 2032, due to the rising incidence of cancer and strong growing demand for advanced treatment technologies in medical settings. The rising investments in healthcare infrastructure and modernization of medical facilities is boosting the adoption of advanced particle accelerators for diagnostic and therapeutic purposes. Growing government initiatives for developing and upgrading scientific and medical infrastructure will contribute to the regional product demand.

Product Code: 9664

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing demand for radiotherapy treatments
      • 3.2.1.2 Increasing awareness towards early cancer diagnosis and treatment
      • 3.2.1.3 Growing approvals for advanced radiotherapies
      • 3.2.1.4 Favourable reimbursement policies for radiotherapies
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost associated to linear particle accelerator
      • 3.2.2.2 Safety concerns related to radiation exposure
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 High-energy machine
  • 5.3 Medium-energy machine
  • 5.4 Low-energy machine

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 X-Ray
  • 6.3 Electron
  • 6.4 Proton
  • 6.5 Ion beam
  • 6.6 Other technologies

Chapter 7 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Conventional linear particle accelerator
  • 7.3 Stereotactic radiosurgery & stereotactic body radiotherapy
  • 7.4 Intensity-modulated radiation therapy
  • 7.5 Volumetric modulated arc therapy
  • 7.6 Image-guided radiation therapy
  • 7.7 Other treatment types

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Prostate cancers
  • 8.3 Breast cancers
  • 8.4 Lung cancers
  • 8.5 Colorectal cancers
  • 8.6 Head & neck cancers
  • 8.7 Other applications

Chapter 9 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals
  • 9.3 Radiology clinics
  • 9.4 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11 Company Profiles

  • 11.1 AccSys Technology, Inc.
  • 11.2 Accuray Incorporated
  • 11.3 Altair Technologies, Inc.
  • 11.4 Brainlab AG
  • 11.5 Carl Zeiss Meditec AG
  • 11.6 Elekta
  • 11.7 Laird Technologies, Inc.
  • 11.8 MITSUBISHI HEAVY INDUSTRIES, LTD.
  • 11.9 Panacea Medical Technologies Pvt. Ltd.
  • 11.10 S.I.T. Sordina IORT Technologies S.p.A.
  • 11.11 SHINVA MEDICAL INSTRUMENT CO., LTD.
  • 11.12 Siemens Healthineers AG
  • 11.13 Varian Medical Systems, Inc.
  • 11.14 VIEWRAY TECHNOLOGIES, INC.
  • 11.15 VIVIRAD S.A.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!